Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -13.67% vs 5.09% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -25.45% vs 1.58% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -31.43% vs 20.69% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -32.00% vs 25.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Zhejiang Anglikang Pharmaceutical Co. Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 10.45% vs -17.41% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -13.67% vs 5.09% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 123.35% vs -43.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -25.45% vs 1.58% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 78.46% vs -10.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -31.43% vs 20.69% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 3.03% vs 3.13% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -32.00% vs 25.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






